Which mutual funds hold Sun Pharmaceutical is a critical question for Indian investors with SIP portfolios, as Sun Pharmaceutical Industries Limited (NSE: SUNPHARMA) currently trades at Rs.1,871.1, down 1.07% today, and remains a top holding across numerous equity mutual fund schemes with significant pharma sector exposure. Understanding mutual fund holdings in Sun Pharmaceutical helps retail investors assess their indirect exposure to India’s largest pharmaceutical company, avoid portfolio concentration risk, and make informed decisions about starting or continuing SIPs in funds heavily invested in this blue-chip pharma stock. This comprehensive analysis reveals which fund categories hold SUNPHARMA, how much weightage index and active funds assign to it, and what changing MF holdings signal about institutional conviction in this Rs.4.49 lakh crore market cap giant.
| Parameter | Value |
|---|---|
| Current Price | Rs.1,871.1 |
| Day Change | -1.07% (Down Rs.20.3) |
| Day Range | Rs.1,861.5 – Rs.1,903 |
| 52-Week Range | Rs.1,548 – Rs.1,916.6 |
| Volume (Today) | 5,89,466 shares |
| Sector | Pharmaceuticals |
| Index Membership | Nifty 50, Sensex, Nifty Pharma |
Why Knowing Your MF Exposure to Sun Pharmaceutical Matters
Understanding which mutual funds hold Sun Pharmaceutical protects SIP investors from unintentional portfolio concentration. Many retail investors run multiple SIPs without realizing their cumulative exposure to single stocks. If three of your five SIPs hold significant SUNPHARMA positions, you face higher risk than anticipated.
Moreover, tracking mutual fund holdings in Sun Pharmaceutical reveals institutional investor confidence levels. When top fund houses increase their stakes, it signals bullish sentiment. Conversely, consistent reduction across multiple schemes may indicate concerns about future performance or sector headwinds.
Additionally, this knowledge helps in tax-loss harvesting and portfolio rebalancing strategies. If your direct equity portfolio already contains Sun Pharmaceutical shares, knowing your indirect MF exposure prevents accidental overweighting. This becomes particularly important as the stock trades near its 52-week high of Rs.1,916.6.
Types of Funds That Typically Hold Sun Pharmaceutical
Several mutual fund categories include Sun Pharmaceutical as a core holding. Index funds tracking Nifty 50, Sensex, and Nifty Pharma hold SUNPHARMA by mandate. These passive funds must maintain weightage aligned with index composition, providing predictable exposure.
Furthermore, large-cap equity funds frequently feature Sun Pharmaceutical among their top ten holdings. The company’s market leadership, consistent profitability, and defensive characteristics make it attractive for large-cap fund managers. Flexicap and multicap funds also hold substantial positions, though with more flexibility to adjust weightage.
Sectoral pharma funds naturally carry the highest SUNPHARMA exposure. These specialized schemes often allocate 8-15% of assets to Sun Pharmaceutical, making it their single largest holding. Healthcare-themed funds similarly maintain significant positions in India’s pharmaceutical giant.
| Fund Category | Typical SUNPHARMA Weightage | Holding Nature |
|---|---|---|
| Nifty 50 Index Funds | 2.2-2.8% | Mandatory (Index weight) |
| Sensex Index Funds | 3.0-3.5% | Mandatory (Index weight) |
| Nifty Pharma Index Funds | 18-22% | Mandatory (Sectoral weight) |
| Large Cap Active Funds | 1.5-4.5% | Discretionary |
| Flexicap/Multicap Funds | 1.0-3.8% | Discretionary |
| Pharma Sectoral Funds | 8-15% | High conviction |
| Healthcare Thematic Funds | 6-12% | Strategic holding |
Nifty and Sensex Index Fund Weightage
Index funds provide the most transparent answer to which mutual funds hold Sun Pharmaceutical. As a Nifty 50 constituent, SUNPHARMA typically carries 2.2-2.8% weightage in Nifty index funds. This weightage fluctuates based on free-float market capitalization and quarterly rebalancing.
Sensex index funds maintain slightly higher exposure, usually 3.0-3.5%, since the 30-stock index concentrates holdings compared to Nifty 50. Every SIP rupee invested in Sensex index funds automatically buys a proportionate stake in Sun Pharmaceutical. This passive exposure compounds over time through systematic investing.
Meanwhile, Nifty Pharma index funds carry the highest SUNPHARMA weightage at 18-22%. As the largest pharmaceutical company by market cap, Sun Pharmaceutical dominates this sectoral index. Investors running SIPs in pharma index funds should recognize this substantial single-stock concentration.
Active Fund Manager Conviction Explained
Active fund managers demonstrate conviction through overweight or underweight positions relative to benchmark indices. When a fund manager allocates 4% to SUNPHARMA while the benchmark carries only 2.5%, it signals strong bullish conviction. This overweight position indicates the manager expects Sun Pharmaceutical to outperform peer